BIO

Bio-Rad Laboratories, Inc. (BIO)

Monday, October 19, 2026
Past 1Y
MA21MA180
Signals
BuyEarly buySellEarly sellTurning points
Swing highSwing low
Up dayDown day

Bio-Rad Laboratories (BIO) at a glance

Close · Oct 19, 2026
$352.75
Day change
-0.27%
52-week range
$236.73 – $396.23
Market cap
$9.5B
Sector
Healthcare
Industry
Medical Devices
Exchange
NYSE

Bio-Rad Laboratories stock: what the data says

Bio-Rad Laboratories (BIO) closed at $352.75 on Oct 19, 2026, down 0.3% on the day. The stock is down 6.3% over the past month, up 16.9% over three months, up 16.4% year to date and up 12.9% over the past year. It trades 11.0% below its 52-week high of $396.23 and 49.0% above its 52-week low of $236.73. The close sits below its 50-day moving average ($372.72) and above its 200-day moving average ($311.10).

NextPick tracks BIO in its Life Sciences Tools basket alongside TMO, DHR, A, WAT and MTD. As of Oct 19, 2026, the basket's money-flow score is -6 (neutral), and the basket is up 0.1% over five sessions. Over the past month BIO ranks 10th of 10 basket members by price change.

BIO stock: key questions

Is BIO above its 200-day moving average?

Yes — the Oct 19, 2026 close of $352.75 is 13.4% above the 200-day average of $311.10.

How far is BIO from its 52-week high?

BIO closed 11.0% below its 52-week high of $396.23.

What stocks are similar to BIO?

NextPick groups BIO with TMO, DHR, A, WAT and MTD in its Life Sciences Tools basket.

About Bio-Rad Laboratories, Inc.

Bio-Rad Laboratories, Inc. develops, manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, Latin America, and internationally. It operates through two segments, Life Science and Clinical Diagnostics. The Life Science segment develops, manufactures, and markets instruments, systems, reagents, and consumables to separate, purify, characterize, and quantify biological materials, including cells, proteins, and nucleic acids used in research and biopharmaceutical laboratory environments, as well as for biopharmaceutical manufacturing, quality control process, food safety, and science education applications. This segment serves universities and medical schools, industrial research organizations, government agencies, pharmaceutical manufacturers, biotechnology companies, food producers, and testing laboratories. Its Clinical Diagnostics segment designs, manufactures, markets, and supports diagnostic test systems, informatics systems, test kits, and specialized quality controls for clinical, hospital, diagnostic reference, and transfusion and physician office laboratories, as well as software. The company offers its products through its direct commercial organization, as well as through distributors, agents, brokers, and resellers. Bio-Rad Laboratories, Inc. was founded in 1952 and is headquartered in Hercules, California.

bio-rad.com